Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
21SEP

CMA asks who £400bn procurement buys

2 min read
16:52UTC

The Competition and Markets Authority published "Public procurement in the national interest" on 8 September, questioning whether a system built to count small suppliers does anything for the firms that grow.

TechnologyDeveloping
Key takeaway

The CMA says counting small suppliers and backing firms that scale are different objectives.

The Competition and Markets Authority (CMA), the UK Competition Regulator, published "Public procurement in the national interest" on 8 September, fronted by chair Doug Gurr and chief executive Sarah Cardell⁠1. The paper examines how the state buys from the small and medium-sized enterprise (SME) sector, against the roughly £400 billion the public sector spends on procurement each year.

Its central sentence separates two things British policy has treated as one. "A system optimised to increase the number of SMEs participating is not necessarily the same as a system optimised to support future high-growth, innovative firms," the regulator writes. Counting suppliers rewards breadth. Buying unproven technology rewards a handful of companies that can scale, and the two targets pull procurement officers in opposite directions.

The fifth recommendation asks government to turn procurement from buying known technologies at the lowest risk into a tool for discovering and scaling frontier technologies, meaning technology not yet proven commercially at scale. British policy has instead aimed its procurement levers at participation counts, which leaves the largest single pot of money available to a British scale-up pointed somewhere else.

State money reaches these companies through several channels, and buying power dwarfs the rest. The British Business Bank guaranteed £6.5 billion of smaller-business lending across four years, a programme large enough to matter and still an order of magnitude below what the state spends buying things. Procurement reform costs no new money, which is what makes the CMA's question awkward to answer and cheap to act on.

Deep Analysis

In plain English

The Competition and Markets Authority, the UK's competition watchdog, published a report asking whether the way government spends roughly £400bn a year on contracts, everything from IT systems to construction, makes it too hard for new, fast-growing companies to win that business. The concern is that government tends to keep buying from the same large, familiar suppliers because they are easier to qualify and less risky to pick, even when a smaller company might offer a better or cheaper solution.

Deep Analysis
Root Causes

Public sector framework agreements and pre-qualification questionnaires are built around evidence of prior delivery at scale, financial resilience tests, and standing accreditations, criteria that established suppliers accumulate over repeated contract cycles and that a younger, innovative firm has not yet had the chance to build.

That structural feature, not any single procurement officer's preference, is what the CMA's roughly £400bn question is really aimed at: whether the qualifying criteria themselves are calibrated for continuity over innovation.

What could happen next?
  • Opportunity

    If the CMA's findings lead to simplified qualification routes, high-growth UK firms would gain a larger addressable market in public sector contracts than they currently have.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Competition and Markets Authority· 21 Sept 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.